These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2106595)

  • 1. [Qualitative analysis of tissue plasminogen activator in plasma obtained from various liver diseases by gel filtration and affinity chromatography].
    Takatori M; Kamogawa A; Iwabuchi S; Moriyama N; Mizuguchi A; Sugai J
    Rinsho Byori; 1990 Jan; 38(1):71-5. PubMed ID: 2106595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
    Matsuura R; Soma M; Maeda Y; Kasakura S
    Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
    Francis RB; Seyfert U
    J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluctuations of tissue-type plasminogen activator.plasminogen activator inhibitor-1 complex in patients with DIC].
    Nagaizumi K; Kuroso K; Amano K; Sato T; Fukutake K; Fujimaki M
    Rinsho Byori; 1994 Jul; 42(7):707-12. PubMed ID: 8065036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
    Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
    Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
    Van Thiel DH; George M; Fareed J
    Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of plasma tissue plasminogen activator (I-PA) levels in patients with liver diseases].
    Maekawa H; Yoshikawa Y; Toda G; Oka H
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jan; 87(1):62-8. PubMed ID: 2109806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
    Crookston KP; Marsh CL; Chandler WL
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance.
    Wiman B; Chmielewska J
    Scand J Clin Lab Invest Suppl; 1985; 177():43-7. PubMed ID: 3934745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
    Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
    Hayashi T
    Rinsho Byori; 1994 Apr; 42(4):346-51. PubMed ID: 8176842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
    Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
    Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.